Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease (Q48159922)

9 February 2018

title

Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease (English)

1 reference

9 February 2018

0 references

0 references

Solveig Horstmann

1

1 reference

9 February 2018

Leila Budig

2

1 reference

9 February 2018

Humphrey Gardner

3

1 reference

9 February 2018

James Koziol

4

1 reference

9 February 2018

Michael Deuschle

5

1 reference

9 February 2018

Claudia Schilling

6

1 reference

9 February 2018

Simone Wagner

7

1 reference

9 February 2018

publication date

18 June 2010

1 reference

9 February 2018

International Psychogeriatrics

published in

1 reference

9 February 2018

volume

22

1 reference

9 February 2018

issue

6

1 reference

9 February 2018

page(s)

966-972

1 reference

9 February 2018

Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

Common inflammatory mechanisms in Lewy body disease and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

Metalloproteinase's activity and oxidative stress in mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

Analysis of functional polymorphisms of metalloproteinase genes in persons with vascular dementia and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

β-Amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

Influences of matrix metalloproteinase-3 gene variation on extent of coronary atherosclerosis and risk of myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

Impact of the matrix metalloproteinase MMP-3 on dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

The role of matrix metalloproteinase-9 in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

Interaction between matrix metalloproteinase 3 and the epsilon4 allele of apolipoprotein E increases the risk of Alzheimer's disease in Finns

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

Proteolysis of A beta peptide from Alzheimer disease brain by gelatinase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

Matrix metalloproteinase 3 haplotypes and dementia and Alzheimer's disease. The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

Matrix metalloproteinase3 and 9 gene promoter polymorphisms: joint action of two loci as a risk factor for coronary artery complicated plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

The importance of inflammatory mechanisms in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

7 January 2021

Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

7 January 2021

Matrix Metalloproteinase Expression After Human Cardioembolic Stroke

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

7 January 2021

Matrix metalloproteinases and their inhibitors in the nervous system: the good, the bad and the enigmatic

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

7 January 2021

Coronary artery calcification is related to functional polymorphism of matrix metalloproteinase 3: the Helsinki Sudden Death Study

1 reference

https://api.crossref.org/works/10.1017%2FS1041610210000827

7 January 2021

10.1017/S1041610210000827

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018